# Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance), Division F: ADDITIONAL INFORMATION:

Extent: E+W+S+N.I.

1.. Global Substantial Modifications;
2.. Global Interruptions and re-starts;
3.. Limitations, addressing sources of potential bias and imprecisions and Caveats;
4.. A declaration by the submitting party on the accuracy of the submitted information.

---
Source: https://www.legislation.gov.uk/eur/2014/536/annex/IV/division/F (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-536/annex-IV/division-F
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.